Influence of Preparative Procedures on Assay of Platelet Function and Apparent Effects of Antiplatelet Agents

American Journal of Cardiology

Volumn 100, Issue 4, 2007, Pages 722-727

  Madsen, Nathaniel J ^a   Holmes, Chris E ^a   Serrano, Feliciano A ^a   Sobel, Burton E ^a   Schneider, David J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ANTITHROMBOCYTIC AGENT; CANGRELOR; CONVULXIN; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; TIROFIBAN; TRYPSIN INHIBITOR;

ARTICLE; BLOOD SAMPLING; CELL ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; BENZOTHIAZOLES; BLOOD PLATELETS; CORONARY DISEASE; CROTALID VENOMS; FLOW CYTOMETRY; FLUORESCENT DYES; HEMOSTATICS; HUMANS; LECTINS, C-TYPE; PLATELET ACTIVATING FACTOR; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; QUINOLINES; THROMBIN; TYROSINE;

EID: 34547697705     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.091     Document Type: Article

References (23)

1. Huo Y., Schober A., Forlow S.B., Smith D.F., Hyman M.C., Jung S., Littman D.R., Weber C., and Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9 (2003) 61-67
2. Fitzgerald D.J., Roy L., Catella F., and Fitzgerald G.A. Platelet activation in unstable coronary disease. N Engl J Med 315 (1986) 983-989
3. Thaulow E., Erikssen J., Sandvik L., Stromorken H., and Cohn P.F. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84 (1991) 613-617
4. Trip M.D., Cats V.M., van Capelle F.J., and Vreeken J. Platelet hyperreactivity and prognosis in survival of myocardial infarction. N Engl J Med 322 (1990) 1549-1554
5. Kabbani S.S., Watkins M.W., Ashikaga T., Terrien E.F., Holoch P.A., Sobel B.E., and Schneider D.J. Platelet reactivity characterized prospectively. A determinant of outcome 90 days after percutaneous coronary intervention. Circulation 104 (2001) 181-186
6. Nylander S., Johansson K., Van Giezen J.J., and Lindahl T.L. Evaluation of platelet function, a method comparison. Platelets 17 (2006) 49-55
7. Gritters M., Grooteman M.P., Schoorl M., Schoorl M., Bartels P.C., Scheffer P.G., Teerlink T., Schalkwijk C.G., Spreeuwenberg M., and Nube M.J. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during hemodialysis. Nephrol Dial Transplant 21 (2006) 153-159
8. Labarthe B., Theroux P., Angioi M., and Ghitescu M. Matching the evaluation of the clinical efficacy of clopidogrel to platelet function tests relevant to the biological properties of the drug. J Am Coll Cardiol 46 (2005) 638-645
9. Marciniak Jr. S.J., Jordan R.E., and Mascelli M.A. Effect of Ca2+ chelation on the platelet inhibitory ability of the GPIIb/IIIa antagonists abciximab, eptifibatide and tirofiban. Thromb Haemost 85 (2001) 539-543
10. Kereiakes D.J., Lorenz T., Young J.J., Kukielka G., Mueller M.N., Nanniazzi-Alaimo L., and Phillips D.R. Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban. J Thromb Thrombolysis 12 (2001) 123-127
11. Rebello S.S., Huang J., Faul J.D., and Lucchesi B.R. Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists. J Thromb Thrombolysis 9 (2000) 23-28
12. Schneider D.J., Tracy P.B., Mann K.G., and Sobel B.E. Differential effects of anticoagulants on the activation of platelets ex vivo. Circulation 96 (1997) 2877-2883
13. Thattaliyath B., Cykowski M., and Jagadeeswaran P. Young thrombocytes initiate the formation of arterial thrombi in zebrafish. Blood 106 (2005) 118-124
14. Schneider D.J., Herrmann H.C., Lakkis N., Aguirre F., Lo M.W., Yin K.C., Aggarwal A., Kabbani S.S., and DiBattiste P.M. Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban. Am J Cardiol 91 (2003) 334-336
15. Achyuthan K.E., Dobson J.V., and Greenberg C.S. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking. Biochim Biophys Acta 872 (1986) 261-268
16. Schneider D.J., Baumann P.Q., Holmes M.B., Taatjes D.J., and Sobel B.E. Time and dose dependent augmentation of inhibitory effects of abciximab by aspirin. Thromb Haemost 85 (2001) 309-313
17. Robinson M., MacHin S., Mackie I., and Harrison P. In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine. Br J Haematol 108 (2000) 859-864
18. Patel D., Vaananen H., Jirouskova M., Hoffmann T., Bodian C., and Coller B.S. Dynamics of GPIIb/IIIa-mediated platelet-platelet interactions in platelet adhesion/thrombus formation on collagen in vitro as revealed by videomicroscopy. Blood 101 (2003) 929-936
19. Phillips D.R., Teng W., Arfsten A., Nannizzi-Alaimo L., White M.M., Longhurst C., Shattil S.J., Randolph A., Jakubowski J.A., Jennings L.K., and Scarborough R.M. Effect of Ca2+ on GP IIb-IIIa interactions with integrelin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in concentration of ionized calcium in plasma anticoagulated with citrate. Circulation 96 (1997) 1488-1494
20. Roger S., Pawlowski M., Habib A., Jandrot-Perrus M., Rosa J.P., and Bryckaert M. Costimulation of the Gi-coupled ADP receptor and the Gq-coupled TXA2 receptor is required for ERK2 activation in collagen-induced platelet aggregation. FEBS Lett 556 (2004) 227-235
21. Larson M.K., Chen H., Kahn M.L., Taylor A.M., Fabre J.E., Mortensen R.M., Conley P.B., and Parise L.V. Identification of P2Y12-dependent and -independent mechanisms of glycoprotein VI-mediated Rap1 activation in platelets. Blood 101 (2003) 1409-1415
22. Kim S., Foster C., Lecchi A., Quinton T.M., Prosser D.M., Jin J., Cattaneo M., and Kunapuli S.P. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood 99 (2002) 3629-3636
23. Schoenfeld H., Muhm M., Doepfmer U., Exadaktylos A., and Radtke H. Platelet activity in washed platelet concentrations. Anesth Analg 99 (2004) 17-20